Edward M. Rudnic, President and CEO at MiddleBrook Pharmaceuticals, Inc. (MBRK), sold 27,400 shares at $1.56 ($42K) on 2007-10-16, disclosed to the SEC on 2007-10-17.
Scheduled sale ($42k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.56 | 1,100 | $2K | 4.1% |
| 2 | $1.57 | 1,000 | $2K | 3.8% |
| 3 | $1.58 | 3,145 | $5K | 11.9% |
| 4 | $1.59 | 700 | $1K | 2.7% |
| 5 | $1.60 | 247 | $395 | 0.9% |
| 6 | $1.61 | 600 |
| $966 |
| 2.3% |
| 7 | $1.62 | 755 | $1K | 2.9% |
| 8 | $1.63 | 153 | $249 | 0.6% |
| 9 | $1.52 | 200 | $304 | 0.7% |
| 10 | $1.53 | 400 | $612 | 1.5% |
| 11 | $1.54 | 6,701 | $10K | 24.7% |
| 12 | $1.55 | 1,399 | $2K | 5.2% |
| 13 | $1.56 | 200 | $312 | 0.7% |
| 14 | $1.57 | 100 | $157 | 0.4% |
| 15 | $1.45 | 1,600 | $2K | 5.5% |
| 16 | $1.46 | 1,400 | $2K | 4.9% |
| 17 | $1.47 | 6,000 | $9K | 21.1% |
| 18 | $1.49 | 400 | $596 | 1.4% |
| 19 | $1.51 | 300 | $453 | 1.1% |
| 20 | $1.52 | 900 | $1K | 3.3% |
| 21 | $1.53 | 100 | $153 | 0.4% |
| Total | $1.53 avg | 27,400 | $42K | 100% |
| Filing → |
| MBRK | SELL | 2007-11-23 | $20K | — | Filing → |
| MBRK | SELL | 2007-10-18 | $18K | — | Filing → |
| MBRK | SELL | 2007-09-19 | $90K | — | Filing → |